Blockage of cytochrome oxidase 2 synthesis, which inhibits glycolysis, and upregulation of glucose transporters (SLC2A1 and A4) [136,137] have been found in p53-mutated GBM. This evidence concerns the gene SLC2A1 and glioblastoma.